Fermata Advisors LLC Has $1.04 Million Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Fermata Advisors LLC grew its stake in shares of The Procter & Gamble Company (NYSE:PG) by 10.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,027 shares of the company’s stock after buying an additional 567 shares during the quarter. Fermata Advisors LLC’s holdings in Procter & Gamble were worth $1,044,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Wulff Hansen & CO. lifted its holdings in shares of Procter & Gamble by 16,292.0% during the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock worth $606,230,000 after purchasing an additional 3,653,477 shares during the period. TD Asset Management Inc lifted its holdings in Procter & Gamble by 114.9% during the 1st quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock worth $579,017,000 after buying an additional 1,907,716 shares during the period. AMF Tjanstepension AB grew its position in shares of Procter & Gamble by 416.1% in the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after buying an additional 1,466,115 shares during the last quarter. Swedbank AB acquired a new stake in shares of Procter & Gamble in the first quarter valued at about $233,788,000. Finally, Ilex Capital Partners UK LLP bought a new position in shares of Procter & Gamble during the first quarter worth about $228,212,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 0.9 %

Shares of PG stock traded up $1.53 during midday trading on Friday, reaching $170.48. 2,259,413 shares of the stock were exchanged, compared to its average volume of 6,662,746. The Procter & Gamble Company has a 1 year low of $141.66 and a 1 year high of $177.94. The firm has a market cap of $402.36 billion, a PE ratio of 28.27, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The company’s 50 day moving average is $171.45 and its two-hundred day moving average is $166.66. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PG) last announced its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same quarter in the previous year, the business posted $1.37 EPS. The company’s quarterly revenue was down .1% on a year-over-year basis. On average, equities research analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.36%. Procter & Gamble’s dividend payout ratio (DPR) is presently 66.94%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 383,194 shares of company stock worth $65,140,718. Corporate insiders own 0.18% of the company’s stock.

Wall Street Analyst Weigh In

PG has been the topic of several recent analyst reports. Citigroup boosted their target price on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Evercore ISI raised their target price on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a report on Thursday, August 29th. Stifel Nicolaus increased their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research note on Monday, July 22nd. Finally, Jefferies Financial Group lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price objective for the company from $182.00 to $175.00 in a report on Wednesday, July 24th. Ten research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $175.05.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.